December 28, 2022 3-5PM ET
Wednesday on The Robert Scott Bell Show:
Special Guest Dr. Richard Fleming, PhD, MD, JD
In 1994, Dr. Fleming presented to the American Heart Association his “theory” that cardiovascular disease was due to inflammation. What was theory in 1994 has become well known fact for decades and was highlighted in 2004,with a feature on ABC’s 20/20 News. Patent # 9566037 was issued to Dr. Fleming on February 14, 2017. The Fleming Method patent (FMTVDM) covers ALL methods and devices able to measure metabolic and regional blood flow differences. This breakthrough made it possible to differentiate functionality of tissue, tissue types as well as non-tissue, and the measurement of treatment response using all isotopes, enhancing agents and devices capable of detecting and measuring isotopes. Developing technology that disrupts the methods of conventional medicine is not always welcomed. Especially when that technology would half the revenue a $20 billion nuclear isotope industry. When physicians bring innovation to medicine, complaints to medical boards often follow along with court cases, which is why it’s called, “Disruptive Technology.” His knowledge and patent enables previously undetectable inflammation to be seen and measured with levels of accuracy not found in most common scanning and technologies or devices.
Worker who lowered Vermont town’s fluoride for years resigns A town employee who quietly lowered the fluoride in a Vermont community’s drinking water for years has resigned — and is asserting that the levels had actually been low for much longer than believed. Richmond water superintendent Kendall Chamberlin disclosed in his five-page resignation letter, submitted Monday, that fluoride levels have not been in the state-recommended range for over a decade — instead of nearly four years, as the state had recently disclosed. Chamberlin said in his letter — in language that at times echoes unfounded reports that have circulated online in recent years — that he doesn’t think the current fluoridation policy is legally required or scientifically sound, and, in his opinion, poses “unacceptable risks to public health.” “I cannot in good conscience be a party to this,” he wrote. Chamberlin wrote that he has never received a negative job review, has each day accurately measured the fluoride levels in the water, and has provided monthly written reports that were approved and signed by the town manager and submitted to two state agencies.
Hour 2 – Special Guest Dr. Rashid Buttar
Dr. Rashid A. Buttar received his undergraduate degree from Washington University in St. Louis with a double major in Biology and Theology and then attended medical school at the University of Osteopathic Medicine and Health Sciences, College of Osteopathic Medicine and Surgery in Des Moines, Iowa. He trained in General Surgery and Emergency Medicine and served as Brigade Surgeon for 2nd Infantry Division, Republic of South Korea, and later as Chief of theDepartment of Emergency Medicine at Moncrief Army Community Hospital at Ft. Jackson in Columbia, South Carolina while serving in the US Army. During his military career, Dr. Buttar had the privilege of serving with and being attached to the 2nd Infantry Division, the 101st Air Assault Division and the 5th Special Forces Group. Dr. Buttar is board certified and a Diplomate in Clinical Metal Toxicology and Preventive Medicine, is board eligible in Emergency Medicine and has achieved fellowship status in three separate medical organizations (Fellow of the American College for Advancement in Medicine, Fellow of the American Academy of Preventive Medicine, and Fellow of the American Association of Integrative Medicine). Dr. Buttar practices in Charlotte, NC where he is the medical director of Advanced Concepts in Medicine, The Center for Advanced Medicine and Clinical Research. The Center specializes in the treatment and needs of patients refractory to conventional treatments and who have failed the standard approach to their disease process. With a special emphasis on the interrelationship between environmental toxicity and the insidious disease processes and the “up regulation” of the immune system, the Center has attracted patients from 34 different countries all over the world suffering from cancer, heart disease, stroke, autism and many other conditions too numerous to list.
‘Child Abuse on a Massive Scale’: CDC Advisers Recommend Adding COVID Vaccines to Childhood Schedule The Centers for Disease Control and Prevention’s (CDC) independent vaccine advisory committee today voted unanimously (15-0) to recommend adding COVID-19 vaccines for children as young as 6 months old to the new Child and Adolescent Immunization Schedule, which will be rolled out in February 2023. The revised recommendations accepted today by the committee include the Moderna or Pfizer-BioNTech COVID-19 vaccine for children as young as 6 months old and the Novavax COVID-19 vaccine for children as young as 12. All COVID-19 vaccines being administered in the U.S. to people under 18 are Emergency Use Authorized (EUA) products. The U.S. Food and Drug Administration did grant full approval to Pfizer’s Comirnaty COVID-19 vaccine for ages 12 and older, however, the Comirnaty vaccine is not available in the U.S. — which means all children who get the Pfizer vaccine are getting an EUA product. When asked if an EUA product could be added to the schedule, Dr. A. Patricia Wodi, a member of the CDC’s Advisory Committee on Immunization Practices (ACIP), said the U.S. Department of Health and Human Services Office of General Counsel confirmed for the CDC that EUA products can be added. Commenting on Wodi’s statement, Dr. Meryl Nass said, “And that was that. No legal justification. No moral or ethical justification. And definitely no medical or scientific justification.” Nass said she isn’t aware of any EUA product ever being added to the schedule until today.
A common respiratory virus is spreading at unusually high levels, overwhelming children’s hospitals. Here’s what parents need to know When Amber Sizemore and her family went out of state to celebrate her birthday last week, she had hoped her toddler daughter, Raegan, would try swimming. But the 15-month-old, normally energetic and adventurous, wasn’t herself on Saturday. “She hated it, and she normally loves water,” Sizemore said. By Sunday, when the family was heading back to Ohio, the little girl was “coughing like crazy.” “She coughed so hard, she threw up,” Sizemore said. Raegan also stopped eating and developed a fever. When Tylenol didn’t help, Sizemore took her to urgent care and told them that RSV or respiratory syncytial virus, a common cold-like virus, was going around at Raegan’s day care, where Sizemore also works. The test came back positive, and Raegan’s vital signs prompted the staffers at the urgent care to tell Sizemore to take her daughter to the hospital. As soon as they saw her vitals, the staff at UH Rainbow Babies & Children’s Hospital in Cleveland knew they had to admit Raegan, her mom said. She needed oxygen. “They’ve been great here and taken good care of her, but the scariest part is, had I not already known she was exposed to RSV, I may have just let her cough it out,” Sizemore said. “I’m glad I didn’t wait.” Most kids catch RSV at some point before they turn 2, the US Centers for Disease Control and Prevention says, and it’s usually mild. Symptoms may look like a common cold and include runny nose, decreased appetite, coughing, sneezing, fever and wheezing. They typically last a week or two, and clear up with rest and fluids. But in some children, especially young infants, RSV can be dangerous, leading to dehydration, breathing trouble and more serious illnesses such as bronchiolitis or pneumonia.
Medical group urges medication, not just diet and exercise, to treat obesity New guidelines released Thursday urge doctors to pair certain medications with lifestyle changes for overweight and obese adult patients to increase their chance of successful weight loss over the long term. The American Gastroenterological Association, which issued the recommendations, underscored that obesity is a biological disease, not a lifestyle problem, that affects more than 4 in 10 U.S. adults, up from 30.5% over the past two decades. The Centers for Disease Control and Prevention says obesity is “a common, serious and costly disease.” The clinical practice guidelines, published in the journal Gastroenterology, recommend medications that, when paired with healthy eating and regular physical activity, are first-line medical options to be used as initial, or primary treatment, and can result in moderate weight loss. The four drugs suggested in the guidelines as safe and effective for long-term weight management are Wegovy, or semaglutide, with a 10.8% weight-loss percentage; Qsymia, or phentermine-topiramate ER, 8.5%; Saxenda, or liraglutide, 4.8%; and Contrave, or naltrexone-bupropion ER, 3.0%.